Endologix to Present at UBS Global Life Sciences Conference
September 22 2005 - 4:00AM
Business Wire
Endologix, Inc. (Nasdaq:ELGX) today announced that Paul McCormick,
president and chief executive officer, will make a presentation to
the investment community at the UBS Global Life Sciences Conference
on Thursday, September 29, 2005 at 8:00 a.m. Eastern Time (5:00
a.m. Pacific Time) at the Grand Hyatt Hotel in New York City.
Interested investors may gain access to a live audio webcast of the
presentation and accompanying slides via the Internet by visiting
the Company's Web site at www.endologix.com. The presentation will
be available and archived on the Web site for 30 days. About
Endologix Endologix, Inc. develops and manufactures minimally
invasive treatments for vascular diseases. Endologix's Powerlink(R)
System is an endoluminal stent graft for treating abdominal aortic
aneurysms (AAA). AAA is a weakening of the wall of the aorta, the
largest artery in the body, resulting in a balloon-like
enlargement. Once AAA develops, it continues to enlarge and, if
left untreated, becomes increasingly susceptible to rupture. The
overall patient mortality rate for ruptured AAA is approximately
75%, making it the thirteenth leading cause of death in the U.S. In
October 2004, Endologix received approval to market the Powerlink
in the U.S. Additional information can be found on Endologix's Web
site at www.endologix.com.
Endologix (NASDAQ:ELGX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Endologix (NASDAQ:ELGX)
Historical Stock Chart
From Jul 2023 to Jul 2024